Education
About Us
Working with TipRanks
Follow Us
Dannielle Appelhans Insider Profile
4 Followers
Dannielle Appelhans, CEO & President at Rubius Therapeutics, holds 0.00 shares in Generation Bio (Ticker: GBIO), holds 0.00 shares in Rubius Therapeutics (Ticker: RUBY).
Dannielle Appelhans Rubius Therapeutics (RUBY)CEO & President
Rubius Therapeutics (RUBY)
CEO & President
Ranked #75,231 out of 106,487 Corporate Insiders
Profitable Transactions
0 out of 2 Profitable Transactions
Average Return
-25.10%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Dannielle Appelhans does not currently own shares as a corporate insider.
A breakdown of Dannielle Appelhans's holdings
Insider Roles
Dannielle Appelhans does not currently hold a role as a corporate insider.
Roles that Dannielle Appelhans holds in companies
Most Profitable Insider Trade
Stock:
Generation Bio
(GBIO)
(GBIO)
Rating:Informative Buy
Date:Dec 06, 2023 - Dec 06, 2024
Return:-21.60%
The most profitable trade made by Dannielle Appelhans
Dannielle Appelhans's Trading History
Rubius Therapeutics
Feb 27, 2023
―
Informative Sell
1.25K
$0.00
Generation Bio
Feb 09, 2026
―
Uninformative Sell
―
$0.00
List of latest transactions for each holding click on a transaction to see Dannielle Appelhans's performance on stock
You May Also Like
Dannielle Appelhans insider profile FAQ
What is the percentage of profitable transactions made by Dannielle Appelhans?
The percentage of profitable transactions made by Dannielle Appelhans is 0%.
What is the average return per transaction made by Dannielle Appelhans?
The average return per transaction made by Dannielle Appelhans is -25.10%.
What stocks does Dannielle Appelhans hold?
Dannielle Appelhans holds: RUBY, GBIO stocks.
What was Dannielle Appelhans’s latest transaction?
Dannielle Appelhans latest transaction was an Uninformative Sell of ―.
What was Dannielle Appelhans's most profitable transaction?
Dannielle Appelhans’s most profitable transaction was an Informative Buy of GBIO stock on December 6, 2023. The return on the trade was -21.60%.
What is Dannielle Appelhans's role in Rubius Therapeutics?
Dannielle Appelhans's role in Rubius Therapeutics is CEO & President.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.